Selected research
Market Structure
Global Irreversible Electroporation (IRE) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Irreversible Electroporation (IRE) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Irreversible Electroporation (IRE) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Irreversible Electroporation (IRE) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Irreversible Electroporation (IRE) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Irreversible Electroporation (IRE) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Irreversible Electroporation (IRE) include Acutus Medical, AngioDynamics, Kardium, Pulse Biosciences, Boston Scientific, Hangzhou Nuomao Medical Technology, Medtronic, Johnson & Johnson and Surgnova, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Irreversible Electroporation (IRE) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Irreversible Electroporation (IRE) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Irreversible Electroporation (IRE) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Irreversible Electroporation (IRE) market size, projected growth trends, production technologies, key applications, and end-use industries.
Irreversible Electroporation (IRE) Segment by Company
Acutus Medical
AngioDynamics
Kardium
Pulse Biosciences
Boston Scientific
Hangzhou Nuomao Medical Technology
Medtronic
Johnson & Johnson
Surgnova
Nortion
Shineyo Medical
Tianjin Intelligent Health Medical
Irreversible Electroporation (IRE) Segment by Type
Pulsed Field Ablation System
Steep Pulse Ablation System (NanoKnife)
Irreversible Electroporation (IRE) Segment by Application
Tumors
Cardiac Diseases
Irreversible Electroporation (IRE) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Irreversible Electroporation (IRE) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Irreversible Electroporation (IRE) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Irreversible Electroporation (IRE).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Irreversible Electroporation (IRE) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Irreversible Electroporation (IRE) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Irreversible Electroporation (IRE) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Irreversible Electroporation (IRE) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Pulsed Field Ablation System
- Steep Pulse Ablation System (NanoKnife)
Applications
- Tumors
- Cardiac Diseases
Companies covered
- Acutus Medical
- AngioDynamics
- Kardium
- Pulse Biosciences
- Boston Scientific
- Hangzhou Nuomao Medical Technology
- Medtronic
- Johnson & Johnson
- Surgnova
- Nortion
- Shineyo Medical
- Tianjin Intelligent Health Medical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Irreversible Electroporation (IRE) Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Irreversible Electroporation (IRE) Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Irreversible Electroporation (IRE) Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Irreversible Electroporation (IRE) Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Irreversible Electroporation (IRE) Market Dynamics
- 2.1 Irreversible Electroporation (IRE) Industry Trends
- 2.2 Irreversible Electroporation (IRE) Industry Drivers
- 2.3 Irreversible Electroporation (IRE) Industry Opportunities and Challenges
- 2.4 Irreversible Electroporation (IRE) Industry Restraints
3 Irreversible Electroporation (IRE) Market by Manufacturers
- 3.1 Global Irreversible Electroporation (IRE) Revenue by Manufacturers (2021-2026)
- 3.2 Global Irreversible Electroporation (IRE) Sales by Manufacturers (2021-2026)
- 3.3 Global Irreversible Electroporation (IRE) Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Irreversible Electroporation (IRE) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Irreversible Electroporation (IRE) Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Irreversible Electroporation (IRE) Manufacturers, Product Type & Application
- 3.7 Global Irreversible Electroporation (IRE) Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Irreversible Electroporation (IRE) Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Irreversible Electroporation (IRE) Players Market Share by Revenue in 2025
- 3.8.3 2025 Irreversible Electroporation (IRE) Tier 1, Tier 2, and Tier 3
4 Irreversible Electroporation (IRE) Market by Type
- 4.1 Irreversible Electroporation (IRE) Type Introduction
- 4.1.1 Pulsed Field Ablation System
- 4.1.2 Steep Pulse Ablation System (NanoKnife)
- 4.2 Global Irreversible Electroporation (IRE) Sales by Type
- 4.2.1 Global Irreversible Electroporation (IRE) Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Irreversible Electroporation (IRE) Sales by Type (2021-2032)
- 4.2.3 Global Irreversible Electroporation (IRE) Sales Market Share by Type (2021-2032)
- 4.3 Global Irreversible Electroporation (IRE) Revenue by Type
- 4.3.1 Global Irreversible Electroporation (IRE) Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Irreversible Electroporation (IRE) Revenue by Type (2021-2032)
- 4.3.3 Global Irreversible Electroporation (IRE) Revenue Market Share by Type (2021-2032)
5 Irreversible Electroporation (IRE) Market by Application
- 5.1 Irreversible Electroporation (IRE) Application Introduction
- 5.1.1 Tumors
- 5.1.2 Cardiac Diseases
- 5.2 Global Irreversible Electroporation (IRE) Sales by Application
- 5.2.1 Global Irreversible Electroporation (IRE) Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Irreversible Electroporation (IRE) Sales by Application (2021-2032)
- 5.2.3 Global Irreversible Electroporation (IRE) Sales Market Share by Application (2021-2032)
- 5.3 Global Irreversible Electroporation (IRE) Revenue by Application
- 5.3.1 Global Irreversible Electroporation (IRE) Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Irreversible Electroporation (IRE) Revenue by Application (2021-2032)
- 5.3.3 Global Irreversible Electroporation (IRE) Revenue Market Share by Application (2021-2032)
6 Global Irreversible Electroporation (IRE) Sales by Region
- 6.1 Global Irreversible Electroporation (IRE) Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Irreversible Electroporation (IRE) Sales by Region (2021-2032)
- 6.2.1 Global Irreversible Electroporation (IRE) Sales by Region (2021-2026)
- 6.2.2 Global Irreversible Electroporation (IRE) Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Irreversible Electroporation (IRE) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Irreversible Electroporation (IRE) Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Irreversible Electroporation (IRE) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Irreversible Electroporation (IRE) Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Irreversible Electroporation (IRE) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Irreversible Electroporation (IRE) Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Irreversible Electroporation (IRE) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Irreversible Electroporation (IRE) Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Irreversible Electroporation (IRE) Revenue by Region
- 7.1 Global Irreversible Electroporation (IRE) Revenue by Region
- 7.1.1 Global Irreversible Electroporation (IRE) Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Irreversible Electroporation (IRE) Revenue by Region (2021-2026)
- 7.1.3 Global Irreversible Electroporation (IRE) Revenue by Region (2027-2032)
- 7.1.4 Global Irreversible Electroporation (IRE) Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Irreversible Electroporation (IRE) Revenue (2021-2032)
- 7.2.2 North America Irreversible Electroporation (IRE) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Irreversible Electroporation (IRE) Revenue (2021-2032)
- 7.3.2 Europe Irreversible Electroporation (IRE) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Irreversible Electroporation (IRE) Revenue (2021-2032)
- 7.4.2 Asia-Pacific Irreversible Electroporation (IRE) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Irreversible Electroporation (IRE) Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Irreversible Electroporation (IRE) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Acutus Medical
- 8.1.1 Acutus Medical Company Information
- 8.1.2 Acutus Medical Business Overview
- 8.1.3 Acutus Medical Irreversible Electroporation (IRE) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Acutus Medical Irreversible Electroporation (IRE) Product Portfolio
- 8.1.5 Acutus Medical Recent Developments
- 8.2 AngioDynamics
- 8.2.1 AngioDynamics Company Information
- 8.2.2 AngioDynamics Business Overview
- 8.2.3 AngioDynamics Irreversible Electroporation (IRE) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 AngioDynamics Irreversible Electroporation (IRE) Product Portfolio
- 8.2.5 AngioDynamics Recent Developments
- 8.3 Kardium
- 8.3.1 Kardium Company Information
- 8.3.2 Kardium Business Overview
- 8.3.3 Kardium Irreversible Electroporation (IRE) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Kardium Irreversible Electroporation (IRE) Product Portfolio
- 8.3.5 Kardium Recent Developments
- 8.4 Pulse Biosciences
- 8.4.1 Pulse Biosciences Company Information
- 8.4.2 Pulse Biosciences Business Overview
- 8.4.3 Pulse Biosciences Irreversible Electroporation (IRE) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Pulse Biosciences Irreversible Electroporation (IRE) Product Portfolio
- 8.4.5 Pulse Biosciences Recent Developments
- 8.5 Boston Scientific
- 8.5.1 Boston Scientific Company Information
- 8.5.2 Boston Scientific Business Overview
- 8.5.3 Boston Scientific Irreversible Electroporation (IRE) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Boston Scientific Irreversible Electroporation (IRE) Product Portfolio
- 8.5.5 Boston Scientific Recent Developments
- 8.6 Hangzhou Nuomao Medical Technology
- 8.6.1 Hangzhou Nuomao Medical Technology Company Information
- 8.6.2 Hangzhou Nuomao Medical Technology Business Overview
- 8.6.3 Hangzhou Nuomao Medical Technology Irreversible Electroporation (IRE) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Hangzhou Nuomao Medical Technology Irreversible Electroporation (IRE) Product Portfolio
- 8.6.5 Hangzhou Nuomao Medical Technology Recent Developments
- 8.7 Medtronic
- 8.7.1 Medtronic Company Information
- 8.7.2 Medtronic Business Overview
- 8.7.3 Medtronic Irreversible Electroporation (IRE) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Medtronic Irreversible Electroporation (IRE) Product Portfolio
- 8.7.5 Medtronic Recent Developments
- 8.8 Johnson & Johnson
- 8.8.1 Johnson & Johnson Company Information
- 8.8.2 Johnson & Johnson Business Overview
- 8.8.3 Johnson & Johnson Irreversible Electroporation (IRE) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Johnson & Johnson Irreversible Electroporation (IRE) Product Portfolio
- 8.8.5 Johnson & Johnson Recent Developments
- 8.9 Surgnova
- 8.9.1 Surgnova Company Information
- 8.9.2 Surgnova Business Overview
- 8.9.3 Surgnova Irreversible Electroporation (IRE) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Surgnova Irreversible Electroporation (IRE) Product Portfolio
- 8.9.5 Surgnova Recent Developments
- 8.10 Nortion
- 8.10.1 Nortion Company Information
- 8.10.2 Nortion Business Overview
- 8.10.3 Nortion Irreversible Electroporation (IRE) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Nortion Irreversible Electroporation (IRE) Product Portfolio
- 8.10.5 Nortion Recent Developments
- 8.11 Shineyo Medical
- 8.11.1 Shineyo Medical Company Information
- 8.11.2 Shineyo Medical Business Overview
- 8.11.3 Shineyo Medical Irreversible Electroporation (IRE) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Shineyo Medical Irreversible Electroporation (IRE) Product Portfolio
- 8.11.5 Shineyo Medical Recent Developments
- 8.12 Tianjin Intelligent Health Medical
- 8.12.1 Tianjin Intelligent Health Medical Company Information
- 8.12.2 Tianjin Intelligent Health Medical Business Overview
- 8.12.3 Tianjin Intelligent Health Medical Irreversible Electroporation (IRE) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Tianjin Intelligent Health Medical Irreversible Electroporation (IRE) Product Portfolio
- 8.12.5 Tianjin Intelligent Health Medical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Irreversible Electroporation (IRE) Value Chain Analysis
- 9.1.1 Irreversible Electroporation (IRE) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Irreversible Electroporation (IRE) Production Mode & Process
- 9.2 Irreversible Electroporation (IRE) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Irreversible Electroporation (IRE) Distributors
- 9.2.3 Irreversible Electroporation (IRE) Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst